Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Completed 2 Active not recruiting 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Specimen Handling 76 Cisplatin 64 Drug Therapy 63 Carboplatin 63 Bevacizumab 63 Magnetic Resonance Spectroscopy 59 Radiotherapy 57 Gemcitabine 54 Cyclophosphamide 54 pembrolizumab 52 Oxaliplatin 49 Capecitabine 49 toripalimab 44 Paclitaxel 40 tislelizumab 39 Standard of Care 39 fludarabine 36 Injections 34 Fluorouracil 34 Biopsy 34 venetoclax 33 Blood Specimen Collection 31 Immune Checkpoint Inhibitors 30 anlotinib 28 Nivolumab 28 Surgical Procedures, Operative 27 Irinotecan 27 Docetaxel 27 Leucovorin 26 Dexamethasone 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × MLN 8237 × 1 year × Clear all

NCT07465757 2026-03-12

ALISCA-Lung2

Puma Biotechnology, Inc.

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡